COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 818: Articles 8171-8180  | Next

Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors
Gruber, R., Montilva Ludewig, M. V., Wessels, C., Schlang, G., Jedhoff, S., Herbrandt, S., Mattner, F.
10.1101/2022.03.22.22272770 — Posted: 2022-03-22
Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022
Wegrzyn, R. D., Appiah, G. D., Morfino,, R., Milford, S. R., Walker, A. T., Ernst, E. T., Darrow, W. W., Li, S. L., Robison, K., MacCannell, D., Dai, D., Girinathan, B. P., Hicks, A. L., Cosca, B., Woronoff, G., Plocik, A. M., Simen, B. B., Moriarty, L., Guagliardo, S. A. J., Cetron, M. S., Friedman, C. R.
10.1101/2022.03.21.22272490 — Posted: 2022-03-22
Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands
Han, A. X., Kozanli, E., Koopsen, J., Vennema, H., RIVM COVID-19 molecular epidemiology group, , Hajji, K., Kroneman, A., van Walle, I., Klinkenberg, D., Wallinga, J., Russell, C. A., Eggink, D., Reusken, C. B. E. M.
10.1101/2022.03.21.22272611 — Posted: 2022-03-22
High neutralizing antibody levels against SARS-CoV-2 Omicron after UB-612 booster vaccination
Guirakhoo, F., Wang, S., Wang, C. Y., Kuo, H.-K., Peng, W.-J., Liu, H., Wang, L., Johnson, M., Hunt, A., Hu, M. M., Monath, T. P., Rumyantsev, A., Goldblatt, D.
10.1101/2022.03.18.484436 — Posted: 2022-03-21
Humoral and cellular immune memory to four COVID-19 vaccines
Zhang, Z., Mateus, J., Coelho, C. H., Dan, J. M., Moderbacher, C. R., Galvez, R. I., Cortes, F. H., Grifoni, A., Tarke, A., Chang, J., Escarrega, E. A., Kim, C., Goodwin, B., Bloom, N. I., Frazier, A., Weiskopf, D., Sette, A., Crotty, S.
10.1101/2022.03.18.484953 — Posted: 2022-03-21
Identification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States
Lacek, K. A., Rambo-Martin, B., Batra, D., Zheng, X.-y., Keller, M. W., Wilson, M., Sheth, M., Davis, M., Burroughs, M., Gerhart, J., Hassell, N., Lee, J., Shepard, S. S., Cook, P. W., Wentworth, D. E., Barnes, J. R., Kondor, R., Paden, C. R., Peacock, T. P. R., Sakaguchi, H.
10.1101/2022.03.19.484981 — Posted: 2022-03-21
More severe pneumonitis in children predicts the need for admission and elevation of some but not all markers of severe Covid-19.
Walsh, P., Hankins, A., Bang, H.
10.1101/2022.03.19.22272644 — Posted: 2022-03-21
An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
Kurdi, A., Weir, N., Mueller, T.
10.1101/2022.03.20.22272664 — Posted: 2022-03-21
The outcome of Gynecologic Cancer Patients With The Covid-19 Infection: A Systematic Review And Meta-Analysis
Winata, I. G. S., Simatupang, J., Polim, A. A., Togar, Y., Tondang, A. E.
10.1101/2022.03.20.22272676 — Posted: 2022-03-21
Evaluation of the Panbio™ COVID-19 Antigen Rapid Diagnostic Test in subjects infected with Omicron using different specimens
Galiez, R. d. M., Bomfim, L. M., Mariani, D., Leitao, I. d. C., Castineiras, A. C. P., Goncalves, C. C. A., da Silva, B. O., Cardoso, P. H., Arruda, M. B., Alvarez, P., Akira, V., Rodrigues, D. G. M., Costa, L., Ferreira Junior, O. C., Castineiras, T. M. P. P., Faffe, D. S., TANURI, A.
10.1101/2022.03.19.22272637 — Posted: 2022-03-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).